Cady B, Stone M D
Department of Surgery, New England Deaconess Hospital, Boston, Massachusetts.
Surg Clin North Am. 1990 Oct;70(5):1047-59. doi: 10.1016/s0039-6109(16)45229-1.
Breast-preservation treatment for primary breast cancer should not be used for all women. Women frequently excluded from consideration for such treatment or who choose not to have it may be elderly and not concerned about cosmetic appearance or live at a distance so that 6 weeks of daily trips to radiotherapy would be inconvenient or even impossible. Also, if radiotherapeutic expertise or facilities are not available, a breast-preservation program is difficult. In Massachusetts, a full course of just over 6000 cGy (4500 cGy to the whole breast and a 1600-cGy local boost) costs roughly $6000. Thus, breast preservation is more expensive than mastectomy even with reconstruction, as patients still frequently require a hospital admission with general anesthesia for an axillary dissection. Although insurance policies cover such expenses, patients who do not have insurance or have inadequate coverage may find the extra expense of the breast-preservation technique burdensome or impossible. Women with a small breast and a proportionately large cancer may have an unsatisfactory cosmetic outcome after appropriate lumpectomy. The cosmetic result in such patients frequently cannot be predicted beforehand; this fact adds emphasis to the need for a two-step process of lumpectomy and then re-evaluation of the cosmetic outcome as well as pathologic features for decisions regarding breast preservation. Finally, women may have strikingly different attitudes toward breast preservation than expected by the surgeon. For some women, the urge to preserve the breast is so strong that they will accept virtually any risk to achieve this option, whereas for other women, the constant anxiety about a recurrence or undergoing radiation therapy is traumatic enough that they readily accept mastectomy. In our referral surgical oncology practice, roughly 60% of patients are currently treated with breast-preservation techniques; the remainder undergo mastectomy, with immediate reconstruction in approximately three fourths of the cases. The proportion of patients who elect to have breast preservation depends greatly on local medical customs and attitudes; the radiotherapeutic skills available; women's attitudes, which frequently are dependent on the local press and publicity; and the surgeon's interest and enthusiasm for such a program. There is no appropriate proportion of patients who should be treated by breast-preservation techniques, but clearly, the proportion of patients so treated increases with experience, acceptability, publicity, and availability. Thus, the selection of breast-preserving therapy for individual patients is a result of an extraordinary array of factors that need to be considered in each patient.(ABSTRACT TRUNCATED AT 400 WORDS)
原发性乳腺癌的保乳治疗并非适用于所有女性。经常被排除在这种治疗考虑范围之外或选择不接受保乳治疗的女性可能年事已高,不太在意外观,或者居住距离较远,以至于每天前往放疗六周会很不方便甚至无法做到。此外,如果缺乏放射治疗专业知识或设施,开展保乳项目也很困难。在马萨诸塞州,一个疗程略超过6000厘戈瑞(全乳照射4500厘戈瑞,局部加量1600厘戈瑞)的费用大约为6000美元。因此,即使进行乳房重建,保乳治疗也比乳房切除术更昂贵,因为患者进行腋窝淋巴结清扫时仍经常需要住院接受全身麻醉。尽管保险政策涵盖此类费用,但没有保险或保险覆盖不足的患者可能会觉得保乳技术的额外费用负担过重或无法承受。乳房较小且癌灶相对较大的女性在进行适当的肿块切除术后可能会有不尽如人意的美容效果。这类患者的美容效果往往无法预先预测;这一事实更凸显了需要采取两步走的过程,即先进行肿块切除术,然后重新评估美容效果以及病理特征,以便做出关于保乳的决策。最后,女性对保乳的态度可能与外科医生的预期大不相同。对一些女性来说,保留乳房的愿望非常强烈,以至于她们几乎会接受任何风险来实现这一选择,而对另一些女性来说,对复发或接受放射治疗的持续焦虑已经足够痛苦,以至于她们很容易接受乳房切除术。在我们的转诊外科肿瘤学实践中,目前大约60%的患者接受保乳技术治疗;其余患者接受乳房切除术,约四分之三的病例会立即进行重建。选择保乳治疗的患者比例在很大程度上取决于当地的医疗习惯和态度、现有的放射治疗技术、女性的态度(这往往取决于当地的媒体报道和宣传)以及外科医生对该项目的兴趣和热情。对于应该接受保乳技术治疗的患者,不存在合适的比例,但显然,接受这种治疗的患者比例会随着经验、可接受性、宣传和可获得性的增加而上升。因此,为个体患者选择保乳治疗是一系列特殊因素综合作用的结果,每个患者都需要考虑这些因素。(摘要截断于400字)